The benefits and limitations of animal models for translational research in neurodegenerative diseases - PubMed (original) (raw)

. 2010 Nov;16(11):1210-4.

doi: 10.1038/nm.2224. Epub 2010 Sep 21.

Affiliations

• PMID: 21052075
• DOI: 10.1038/nm.2224

The benefits and limitations of animal models for translational research in neurodegenerative diseases

Mathias Jucker. Nat Med. 2010 Nov.

Abstract

Age-related neurodegenerative diseases are largely limited to humans and rarely occur spontaneously in animals. Genetically engineered mouse models recapitulate aspects of the corresponding human diseases and are instrumental in studying disease mechanisms and testing therapeutic strategies. If considered within the range of their validity, mouse models have been predictive of clinical outcome. Translational failure is less the result of the incomplete nature of the models than of inadequate preclinical studies and misinterpretation of the models. This commentary summarizes current models and highlights key questions we should be asking about animal models, as well as questions that cannot be answered with the current models.

PubMed Disclaimer

Similar articles

• Mouse models of neurodegeneration: Know your question, know your mouse.
  Fisher EMC, Bannerman DM. Fisher EMC, et al. Sci Transl Med. 2019 May 22;11(493):eaaq1818. doi: 10.1126/scitranslmed.aaq1818. Sci Transl Med. 2019. PMID: 31118292 Review.
• Mouse models rarely mimic the transcriptome of human neurodegenerative diseases: A systematic bioinformatics-based critique of preclinical models.
  Burns TC, Li MD, Mehta S, Awad AJ, Morgan AA. Burns TC, et al. Eur J Pharmacol. 2015 Jul 15;759:101-17. doi: 10.1016/j.ejphar.2015.03.021. Epub 2015 Mar 23. Eur J Pharmacol. 2015. PMID: 25814260
• Use of genetically engineered mice as models for exploring the role of oxidative stress in neurodegenerative diseases.
  Andersen JK. Andersen JK. Front Biosci. 1998 Mar 25;3:c8-16. doi: 10.2741/a259. Front Biosci. 1998. PMID: 9512453 Review.
• Translational therapeutics in genetically engineered mouse models of cancer.
  Olive KP, Politi K. Olive KP, et al. Cold Spring Harb Protoc. 2014 Feb 1;2014(2):131-43. doi: 10.1101/pdb.top069997. Cold Spring Harb Protoc. 2014. PMID: 24492770
• From Reproducibility to Translation in Neurodegenerative Disease.
  Zeiss CJ. Zeiss CJ. ILAR J. 2017 Jul 1;58(1):106-114. doi: 10.1093/ilar/ilx006. ILAR J. 2017. PMID: 28444192

Cited by

• Zebrafish: A complete animal model to enumerate the nanoparticle toxicity.
  Chakraborty C, Sharma AR, Sharma G, Lee SS. Chakraborty C, et al. J Nanobiotechnology. 2016 Aug 20;14(1):65. doi: 10.1186/s12951-016-0217-6. J Nanobiotechnology. 2016. PMID: 27544212 Free PMC article. Review.
• The Increasing Importance of Gene-Based Analyses.
  Cirulli ET. Cirulli ET. PLoS Genet. 2016 Apr 7;12(4):e1005852. doi: 10.1371/journal.pgen.1005852. eCollection 2016 Apr. PLoS Genet. 2016. PMID: 27055023 Free PMC article. Review.
• Cerebral Aβ deposition in an Aβ-precursor protein-transgenic rhesus monkey.
  Chan AWS, Cho IK, Li CX, Zhang X, Patel S, Rusnak R, Raper J, Bachevalier J, Moran SP, Chi T, Cannon KH, Hunter CE, Martin RC, Xiao H, Yang SH, Gumber S, Herndon JG, Rosen RF, Hu WT, Lah JJ, Levey AI, Smith Y, Walker LC. Chan AWS, et al. Aging Brain. 2022;2:100044. doi: 10.1016/j.nbas.2022.100044. Epub 2022 Jun 17. Aging Brain. 2022. PMID: 36589695 Free PMC article.
• A three-dimensional dementia model reveals spontaneous cell cycle re-entry and a senescence-associated secretory phenotype.
  Porterfield V, Khan SS, Foff EP, Koseoglu MM, Blanco IK, Jayaraman S, Lien E, McConnell MJ, Bloom GS, Lazo JS, Sharlow ER. Porterfield V, et al. Neurobiol Aging. 2020 Jun;90:125-134. doi: 10.1016/j.neurobiolaging.2020.02.011. Epub 2020 Feb 19. Neurobiol Aging. 2020. PMID: 32184029 Free PMC article.
• Learning from genetic forms of neurodegeneration.
  Brice A. Brice A. Nat Med. 2010 Dec;16(12):1371. doi: 10.1038/nm1210-1371a. Nat Med. 2010. PMID: 21135841 No abstract available.

References

1. 1. Brain Pathol. 1991 Jul;1(4):287-96 - PubMed
2. 1. Nature. 2009 Jul 16;460(7253):392-5 - PubMed
3. 1. J Neuropathol Exp Neurol. 1988 Nov;47(6):629-41 - PubMed
4. 1. Curr Pharm Biotechnol. 2009 Feb;10(2):236-43 - PubMed
5. 1. Acta Neuropathol. 2008 Jan;115(1):87-95 - PubMed

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Medical

  • MedlinePlus Health Information